ASU to develop early diagnostics against colorectal cancer

Leland Hartwell, Nobel laureate and chief scientist at the Biodesign Insitute's Center for Sustainable Health at Arizona State University

ASU’s Leland Hartwell, Nobel laureate and chief scientist at the Biodesign Institute’s Center for Sustainable Health, spearheaded the agreement with Jianping Wang, director of the SYSU Gastrointestinal Institute of the Sixth Affiliated Hospital in Guangzhou, Guangdong, China.

ASU, China’s Sun Yat-Sen University partner

Arizona State University and China’s Sun Yat-Sen University (SYSU) have formalized a research collaboration aimed at developing early and predictive diagnostics to improve patient outcomes for colorectal cancer.  ASU’s Leland Hartwell, Nobel laureate and chief scientist at the Biodesign Institute’s Center for Sustainable Health, spearheaded the agreement with Jianping Wang, director of the SYSU Gastrointestinal Institute of the Sixth Affiliated Hospital in Guangzhou, Guangdong, China.

“Recent advances in molecular technologies promise great improvements in medical care through prevention and early detection of disease,” Hartwell said.

Read more at ASU News

Should Germany be your medical device’s gateway to Europe

U.S. Commercial Service Webinar:  Germany –  Top Choice for U.S. Medical Technology

Date: Tuesday, September 13, 2011
Time: noon EDT/ 11 a.m. CDT/ 9 a.m. PDT
Place:  Online webinar on your computer
Fee: $75 per person

Join the U.S. Commercial Service’s webinar to gain expertise in using Germany as your gateway into the European Union as well as understanding the reimbursement challenges faced by American companies selling to the German Healthcare Market.  The German Healthcare Market is the largest in Europe.  It was 11.6 % of GDP (2009); employed 5.4 million people; and accounted for expenditures of € 278.3 billion in 2009.  According to the German Medical Technology Association (BVMed), the medical devices segment employed 170,000 and generated expenditures of
€ 25 billion in 2009.Continue reading

Intrinsic Bioprobes, Inc. Acquired by Thermo Fisher

Thermo Fisher Scientific Inc., the world leader in serving science, announced on September 1, 2011  that it has enhanced its workflow for biomarker research and diagnostics by acquiring Tempe, Arizona based  Intrinsic Bioprobes Inc., a manufacturer of unique immuno-enrichment, sample-preparation tools used in quantitative mass spectrometry. The Intrinsic Bioprobes portfolio enables Thermo Fisher to offer its worldwide life science research and clinical diagnostics customers an enhanced solution for quantitative protein biomarker detection.

Continue reading